Explore 3 Stock Ideas & Industry Insights Download Free Report

Announcements

Qiming Corporate GP V Reports 2.9% Stake in Connect Biopharma

A group of seven Qiming-affiliated entities filed Amendment No. 2 to Schedule 13G with the SEC on November 3, 2026, disclosing their beneficial ownership positions in Connect Biopharma Holdings Ltd, a clinical-stage biopharmaceutical company headquartered in San Diego, California, as of a September 30, …

Anjali Anand | 03 November 2026

Juliano de Carvalho Dantas Exercises 35,177 Options at AXIA Energia

Juliano de Carvalho Dantas, Executive Vice President of Innovation, R&D, Digital and IT at AXIA Energia S.A. (OTC:AXIAY), filed a Form 4 on November 3, 2026 disclosing a stock option exercise transaction dated October 30, 2026.

Vinay Lochav | 03 November 2026

Harrell Receives 20,325 UONEK Shares in Oct. 2026 Award

William Edward Harrell Jr., Co-President of Urban One, Inc.'s Audio Division, filed a Form 4 on November 3, 2026, disclosing changes in his beneficial ownership of Urban One Class D shares (UONEK) stemming from transactions on October 30, 2026.

Nitish Kishor | 03 November 2026

Faeth CEO Parikh Gifts 100,000 Shares to Family Trust

Anand Kiran Parikh, President and CEO of Faeth Therapeutics, Inc. (NASDAQ:FTH), filed a Form 4 on November 3, 2026, disclosing a gift of 100,000 shares of common stock to the AKP Irrevocable Trust on October 30, 2026.

Shwetambri Chauhan | 03 November 2026

Antony Prabhu Receives 22,106 Shares as Director Pay

Director Antony Prabhu filed a Form 4 with the SEC on November 3, 2026, disclosing the acquisition of 22,106 shares of reAlpha Tech Corp. common stock on October 30, 2026, as quarterly compensation for board service.

Aditi Sarkar | 03 November 2026

Angelis Receives 22,106 Shares as Q3 Director Pay

Director Dimitrios Angelis filed a Form 4 with the SEC on November 3, 2026, disclosing the acquisition of 22,106 shares of reAlpha Tech Corp. common stock on October 30, 2026, as quarterly director compensation.

Manish Choudhary | 03 November 2026

Swaminathan Balaji Receives 22,106 Shares as Director Pay

Director Swaminathan Balaji filed a Form 4 with the SEC on November 3, 2026, disclosing the acquisition of 22,106 shares of reAlpha Tech Corp. common stock as quarterly director compensation for the quarter ended September 30, 2026.

Aakashdeep | 03 November 2026

Ligand Files 13D Amendment on Pelthos Merger and $33.75M Investment

Ligand Pharmaceuticals Incorporated filed Amendment No. 2 to its Schedule 13D with the SEC on November 3, 2026, disclosing a planned $33,750,000 investment in Pelthos Therapeutics Inc. and the issuer's entry into a merger agreement with Castle Creek Biosciences, Inc., with the triggering event …

Nitish Kishor | 03 November 2026

Welch Dissolves Vicuna Capital I LP, Shifts CRMT Shares

Director Joshua G. Welch filed a Form 4 with the SEC on November 3, 2026, disclosing a series of in-kind liquidation distributions of America's Car-Mart, Inc. common stock from Vicuna Capital I, LP dated October 31, 2026.

Aditi Sarkar | 03 November 2026

Rocket Lab CFO Spice Sells 140,157 Shares on Nov. 2, 2026

Adam C. Spice, Chief Financial Officer of Rocket Lab Corp (NASDAQ:RKLB), filed a Form 4 on November 3, 2026, disclosing the exercise of a stock option and the sale of 140,157 shares of common stock on November 2, 2026, pursuant to a pre-established Rule …

Manish Choudhary | 03 November 2026
Support

Hi! How can we help you today?

Loading…